- Patricia H. Fabel, PharmD, BCPS; Executive Director, Kennedy Pharmacy Innovation Center and Clinical Associate Professor
- Kathy Quarles Moore, BSPharm, RPh, CDM; Clinical Assistant Professor and Lab Director, Community and Compounding Labs
- The impact of vaccines on public health.
- Pharmacists’ roles in immunization.
- Immunologic principles of vaccine development and immunizations.
- Vaccine-preventable diseases and the vaccines used to prevent them.
- Strategies for improving immunization rates.
- Requirements for pharmacists who provide immunization services.
- Read an immunization schedule and identify appropriate vaccines for individuals across the life span and with special needs.
- Educate patients about the benefits of vaccines and dispel myths about vaccines.
- Safely administer vaccines to patients via subcutaneous, intramuscular, intranasal, and intradermal routes.
- Operate an immunization service in compliance with legal and regulatory standards.
- Partner with immunization stakeholders to promote immunizations and the immunization neighborhood.
- Promote public health through immunizations.
- Access regularly updated information about vaccines and their use.
- Effectively communicate with patients and other stakeholders about resources.
- Operate an immunization service in compliance with legal and regulatory standards.
- Click on the links below for more information
- Check-in and Continental Breakfast
- Welcome, Introductions and Acknowledgements
- Clinical Review
- Managing a Pharmacy-Based Immunization Program
- Strategies for Increasing Immunization Rates
- Applying ACIP Immunization Schedules
- Communicating with Patients
- Vaccine Administration Technique
- Transitional/Summary Remarks
- Skills Assessment (note - time requirement is variable based on number of participants)
- Chair: Stephan L. Foster, PharmD, FAPhA; CAPT (Ret) U.S.P.H.S.; Professor, University of Tennessee Health Sciences Center; Memphis, Tennessee
- Lauren B. Angelo, PharmD, MBA; Assistant Dean, Academic Affairs; Associate Professor, Pharmacy Practice; Rosalind Franklin University of Medicine and Science; North Chicago, Illinois
- Jeff Goad, Pharm.D., MPH, FAPhA, FCPhA, FCSHP; Professor and Chair, Department of Pharmacy Practice; Chapman University School of Pharmacy; Irvine, California
- Jean-Venable “Kelly” R. Goode, PharmD, BCPS, FAPhA, FCCP; Professor and Director, Community-Based Pharmacy Residency Program; Virginia Commonwealth University; Richmond, Virginia
- Vincent A. Hartzell, Pharm.D.; President; Hartzell's Pharmacy; Catasauqua, Pennsylvania
- Carrie Foust Koenigsfeld, Pharm.D, FAPhA; Professor of Clinical Sciences; Drake University, College of Pharmacy and Health Sciences; Des Moines, Iowa
- Adam C. Welch, PharmD, MBA, BCACP, FAPhA; Associate Dean for Academic Affairs and Assessment; Bill Gatton College of Pharmacy; East Tennessee State University; Johnson City, Tennessee
- Mitchel C. Rothholz, RPh, MBA, Chief Strategy Officer
- Helen Ali-Sairany, PharmD, Associate Director, Content Development, Education
- Kelly French, Director, Advanced Training
- Misty Knack, Associate Director, Advanced Training
- Bronhed Shaw, Associate Director, Advanced Training.
- Stephan Foster, PharmD, FAPhA, FNAP, has served as a speaker for Merck Vaccines, Pfizer and Seqirus. He has served on advisory boards for Pfizer and Seqirus.
- Jeffrey A. Goad, PharmD, MPH, FCPhA, FCSHP has served as a speaker for Merck Vaccines.
- Carrie Foust Koenigsfeld, PharmD, FAPhA, has served as a speaker for Merck Vaccines and Pfizer.
- Mitchel C. Rothholz, RPh, MBA, declares that his spouse is an employee of Merck and that he has served on advisory boards for Merck and Pfizer.
- All other individuals involved in the development of this material declare no conflicts of interest, real or apparent, and no financial interests in any company, product, or service mentioned in this program, including grants, employment, gifts, stock holdings, and honoraria. APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, please visit the APhA website at www.pharmacist.com/apha-disclosures.
- Conflicts of interest have been resolved through content review by Helen Sairany, PharmD, BCACP, Associate Director of Content Development at the American Pharmacists Association.
- The material presented here does not necessarily reflect the views of the American Pharmacists Association. Every attempt has been made to ensure the accuracy of the information contained herein at the time of writing; however, owing to the nature of pharmacy practice, standards and recommendations change regularly. Pharmacists are advised to verify all information and data before treating patients or employing the practices described in this educational activity.
Date: Aug 25, 2019 12:00 PM - 08:00 PM
- Practice Based
- Describe the effects of immunizations on morbidity and mortality rates of vaccine-preventable diseases in the United States.
- Discuss Healthy People 2020 goals for vaccination rates in the United States.
- Explain the expansion of the role of pharmacists as vaccine providers and describe the status of pharmacists’ authorization to administer vaccines throughout the United States.
- Describe strategies for pharmacists to advocate for pharmacy-based delivery of vaccines.
- Discuss the role of pharmacists as immunizers in emergency preparedness activities.
- Identify resources that are useful for immunization providers and educators.
- Identify the differences between active and passive immunity and describe key elements of each process.
- Explain how vaccines elicit an immune response and provide protection from disease.
- Describe the characteristics of and distinctions among live vaccines, inactivated vaccines, polysaccharide vaccines, and recombinant vaccines.
- Discuss the rationale for timing of vaccine administration and intervals between doses, including vaccine-vaccine spacing and vaccine-antibody spacing.
- Describe principles of herd immunity.
- Describe the epidemiology, clinical features, and potential complications of diseases that can be prevented with vaccines.
- Identify vaccines available in the U.S. market for each vaccine-preventable disease and describe their features.
- Identify the contraindications and precautions for the use of vaccines available in the United States.
- Use recommendations from the Advisory Committee on Immunization Practices to identify target groups for receipt of each vaccine.
- Explain how to apply the pharmacists’ patient care process to immunization services.
- Identify patients with immunization needs.
- Given a patient case, select appropriate vaccines using an immunization schedule from the Advisory Committee on Immunization Practices, and identify appropriate timing, doses, and routes of administration.
- Discuss the rationale for timing for vaccine administration and intervals between doses, including vaccine-vaccine spacing and vaccine-antibody spacing.
- Recall recommended patient screening questions for vaccination and identify valid contraindications for vaccinations.
- Educate patients about the benefits of vaccines and address common concerns about vaccines.
- Provide accurate information that addresses common myths about vaccines.
- Describe the roles of the Vaccine Adverse Event Reporting System in managing vaccine safety.
- Educate patients about potential adverse reactions following the receipt of a vaccine and how to manage them.
- Explain appropriate techniques for intramuscular, subcutaneous, intradermal, and intranasal administration of vaccines.
- Describe the signs and symptoms of adverse reactions to vaccines and procedures that pharmacists should follow to manage various adverse reactions.
- Describe appropriate documentation and follow-up after vaccine administration.
- Describe important considerations when deciding which vaccines to offer.
- Describe physical space requirements for a vaccine service.
- Discuss Occupational Safety and Health Administration regulations for the prevention of employee exposure to bloodborne pathogens and needlestick injury at worksites where immunizations are administered.
- Outline principles and procedures for vaccine storage and handling.
- Discuss workflow options for administering vaccines in pharmacy practice.
- Identify marketing strategies that can be used to promote a pharmacy-based immunization service.
- Explain potential options for obtaining reimbursement and compensation for vaccines and vaccine administration.
- Describe liability issues related to vaccine administration, including the Vaccine Injury Compensation Program.
- Describe strategies for increasing immunization rates, including physician collaborations, community level activities, and immunization coalition activities
- Describe pharmacy operations and a process for administering vaccines in various pharmacy practice settings
- Evaluate patient histories and make patient-specific recommendations based on the appropriate immunization schedule
- Demonstrate effective strategies for communicating with patients who have concerns about vaccines
- Describe current evidence regarding vaccine safety
- Recognize the signs and symptoms of adverse reactions that can occur after vaccination
- Describe procedures for management of patients with adverse reactions to vaccination that constitute an emergency
- List the steps for administering currently available intranasal and intradermal vaccines
- Demonstrate appropriate intramuscular and subcutaneous injection techniques for adult immunization
Kathy Quarles-Moore, B.S.Pharm, RPh, CDM
Patricia Fabel, PharmD, BCPS